Eating disorder is a group of physiological and psychological disorders affecting approximately 1% of the female population worldwide. Although the genetic epidemiology of eating disorder is becoming increasingly clear with accumulated studies, the underlying molecular mechanisms are still unclear. Recently, integration of various high-throughput data expanded the range of candidate genes and started to generate hypotheses for understanding potential pathogenesis in complex diseases. This article presents EDdb (Eating Disorder database), the first evidence-based gene resource for eating disorder. Fifty-nine experimentally validated genes from the literature in relation to eating disorder were collected as the core dataset. Another four datasets with 2824 candidate genes across 601 genome regions were expanded based on the core dataset using different criteria (e.g., protein-protein interactions, shared cytobands, and related complex diseases). Based on human protein-protein interaction data, we reconstructed a potential molecular sub-network related to eating disorder. Furthermore, with an integrative pathway enrichment analysis of genes in EDdb, we identified an extended adipocytokine signaling pathway in eating disorder. Three genes in EDdb (ADIPO (adiponectin), TNF (tumor necrosis factor) and NR3C1 (nuclear receptor subfamily 3, group C, member 1)) link the KEGG (Kyoto Encyclopedia of Genes and Genomes) "adipocytokine signaling pathway" with the BioCarta "visceral fat deposits and the metabolic syndrome" pathway to form a joint pathway. In total, the joint pathway contains 43 genes, among which 39 genes are related to eating disorder. As the first comprehensive gene resource for eating disorder, EDdb (http://eddb.cbi.pku.edu.cn) enables the exploration of gene-disease relationships and cross-talk mechanisms between related disorders. Through pathway statistical studies, we revealed that abnormal body weight caused by eating disorder and obesity may both be related to dysregulation of the novel joint pathway of adipocytokine signaling. In addition, this joint pathway may be the common pathway for body weight regulation in complex human diseases related to unhealthy lifestyle. eating disorder, database, adipocytokine signaling pathway, pathway analysis
information is scattered in the published literature. Only 12 genes with positive evidence are stored in GAD (Genetic Association Database) [5] . A more comprehensive gene resource needs to be developed to acquire a more complete picture of eating disorder.
Common unhealthy lifestyles, such as smoking, can increase the risk of several metabolic disorders including eating disorder, hypertension, obesity, type 2 diabetes mellitus and ischemic heart disease [6] [7] [8] [9] . In particular, the symptoms of eating disorder often overlap with other weightrelated disorders such as obesity because of common unhealthy diets [1016] . Although the cause of obesity and eating disorder is becoming increasingly clearer with large-scale and individual genetic studies, the common molecular pathway underlying abnormal body weight between these two weight-related disorders has not been analysed yet.
Although genome-wide association studies have revealed a number of loci in complex diseases such as obesity [17, 18] , two high-throughput studies on eating disorder were unsuccessful in revealing more loci. One study was designed to scan genomic regions of 182 genes from the literature, but resulted in no significant SNPs (singlenucleotide polymorphisms) for anorexia nervosa [19] . The other genome-wide association study on anorexia nervosa sampled 4766 individuals, but confirmed only one common SNP within OPRD1 (Opioid Receptor, Delta 1) [3] .
Systematic and statistical analysis of genes and their pathways may provide a more complete pathway related to the molecular mechanism underlying eating disorder. The majority of identified genes related to eating disorder can be classified into two groups, which are relevant to the neurotransmitter system and body weight regulation. For neurotransmitters, several systems have been proposed, such as the serotonergic system, noradrenergic system and dopaminergic system, while genes for weight regulation are mainly associated with the leptinergic-melanocortinergic system [20] . The association of the molecular mechanisms of these systems with other relevant diseases remains to be explored.
In this article, we developed an eating disorder gene database, EDdb (Eating Disorder database), for cataloguing genes linked to this disorder. Our data representing genetic knowledge encompasses a collection of all types of evidence including mutation analysis, gene expression, gene association, family-based linkage studies, genome-wide association studies and other functional studies. The focus of this resource is to provide an up-to-date and annotated list of eating disorder candidate genes to serve as reference datasets for understanding its etiology. In addition, we set up a strategy for unveiling novel eating disorder susceptibility genes by protein-protein interactions, shared cytobands or related diseases such as obesity. Based on integrated protein-protein interaction data, we have reconstructed a potential network closely related to eating disorder. Furthermore, our systematic and statistical pathway studies revealed that the abnormal body weight caused by eating disorder may be caused by dysregulation of important signaling events occurring in a joint pathway combining the KEGG (Kyoto Encyclopedia of Genes and Genomes) "adipocytokine signaling pathway" and the BioCarta "visceral fat deposits and the metabolic syndrome" pathway.
Materials and methods

Data collection and automation of gene annotation
The genes related to eating disorder in the core dataset were extracted from 567 abstracts from the year 2010, retrieved by PubMed query '((anorexia nervosa) OR (bulimia nervosa) OR (eating disorder)) AND gene'. The data spanned multiple technology platforms including single-gene mutation analysis, family-based linkage studies, population association studies, gene expression analysis, genome-wide association studies and other functional analyses. Seven raw datasets were prepared for the gene list expansion. The first raw dataset included four controversial genes (DRD3, TNF, UCP2 and UCP3) with equally positive and negative evidence from individual articles. Another literature dataset was collected from the supplement of Pinheiro et al. [19] . In addition, three datasets of related diseases (obesity, bipolar disorder and schizophrenia) were collected from Gene Association Database [5] . For accuracy, we excluded negative records of the three disorders in Gene Association Database. The protein-protein interaction partners of genes in the core dataset were integrated from the BioGRID (September 25, 2011 Version 3.1.81) [21] , HPRD (April 13, 2010 Version 9) [22] , and BIND (downloaded on December 15, 2009) [23] databases. Finally, the last raw dataset contained genes that shared cytobands with genes from the core dataset [24] .
The core dataset will be routinely updated based on newly published literature. In addition to continuous data curation and integration of literature and other disease related databases, we will focus on constructing regulatory networks in humans with emphasis on their regulatory transcription factors and phosphorylation. An automatic annotation pipeline was implemented to integrate functional information about the genes from the Entrez gene database (January 13, 2011) [24] , Gene Ontology annotation, interacting proteins from HPRD/BIND/BioGRID, and OMIM annotation using Perl script and Swiss knife module [22, [25] [26] [27] . Signaling event annotation was added to each gene according to the KEGG LIGAND and BioCarta databases [28, 29] . With the automatic pipeline for data annotation, our database can be easily updated when new versions of external databases such as BioCarta and KEGG LIGAND are available.
Sub-network extraction
To obtain a network of eating disorder genes, we firstly constructed a non-redundant human interactome based on the protein-protein interaction data from the HPRD, IntAct, BioGRID and MINT databases. In addition, we excluded self-interactions, interactions predicted by computational methods, and interactions with other species for five networks. The final interactome contained 12363 nodes and 70019 protein-protein interaction links. The degree of all nodes in this human PPI network followed the power law distribution, P(k)~k b , where P(k) represents the probability that a node interacts with k nodes and b is an exponent with an estimated value of 1.683. This indicated that most genes in this human PPI network were sparsely connected, while a small part of them had relatively high connectivity. Using the Steiner minimal tree algorithm [30] , we extracted the sub-network as an eating disorder-specific network from the whole human interactome. In our implemented algorithm, the sub-network was first constructed with all input genes in the core dataset connected. Finally, a minimum net with input genes connected by shortest path was produced.
Web interface construction
All data and information in EDdb are stored in a MySQL relational database on a Linux server [31] [32] [33] . The database provides a web interface, which allows researchers to browse candidate genes from different features. Web-based queries to the database were implemented in Perl scripts running in an Apache environment. EDdb allows users to do text query, or to run BLAST searches against the sequences in EDdb. For an advanced study, this database provides all nucleotide and protein sequences in a FASTA format for all the entries. Furthermore, cross-references to external databases such as KEGG and iHOP (information hyperlinked over proteins) are included for each record in EDdb. In addition, for each gene in the core dataset, links to the original articles related to eating disorder in the NCBI PubMed database are given (Figure 1 ).
Identification of representative pathways using KOBAS
Throughout the paper, the representative pathways from the KEGG and BioCarta databases for each gene set were identified by KOBAS (KEGG Orthology Based Annotation System) [34] . In these pathway analyses, all human proteincoding genes in KOBAS were set as the background to calculate statistical significance. In addition, the false discovery rate (FDR)-corrected P-values for enriched pathways were adopted based on the hypergeometric test. Finally, the enriched human pathways with corrected P-values of less than 0.01 were identified as over-representative pathways for each gene set.
Empirical resampling for evaluating the relationships between eating disorder and other diseases
To determine whether eating disorder is related to obesity, schizophrenia and bipolar disorder more than expected, we conducted a total of 1000 resamplings. Here, we took the obesity gene for example. During each process, 59 human genes were randomly selected from 45522 human genes in the Entrez gene database (January 13, 2011). We repeated this random process 1000 times. Next, we counted the number of randomly selected node sets (N) whose number of overlapping genes was more than the actual number of overlapping genes [33] . Finally, we calculated the empirical P-value using N/1000 to represent the significance of how the 59 eating disorder genes are related to obesity in gene content. Next, we applied a similar approach to schizophrenia and bipolar disorder. Based on this empirical resampling approach, the empirical P-values for the relationship between the eating disorder gene set and obesity, schizophrenia and bipolar disorder are all less than 0.01.
Results
As the first literature-based data resource for eating disorder, our database provides clearer clues for classifying this disease and reveals an underlying biological pathway model from a genetic view.
Collection of the core dataset, consisting of experimentally verified candidate genes for eating disorder
As shown in Figure 2 , the comprehensive collection of experimentally verified genes in EDdb was accomplished by curating published literature in the following four steps: (i) An extensive literature search was conducted through PubMed with the keywords "eating disorder", "anorexia nervosa", "bulimia nervosa" or "binge eating disorder" (see Materials and methods); (ii) the retrieved abstracts were highlighted with query keywords and grouped by the Related Articles function in Entrez; (iii) the abstracts were manually read to list the experimentally verified candidate genes for eating disorder and other related information such as experimental methods and populations; (iv) the candidate gene names were manually mapped to Entrez Gene ID and automatic annotation was performed (see Materials and methods). We also recorded negative results for each gene, and we assumed that genes with more positive reports were candidate genes. Only four genes (DRD3 (Dopamine Receptor D3), TNF (tumor necrosis factor), UCP2 (uncoupling protein 2) and UCP3 (uncoupling protein 3)) with equal negative and positive reports were excluded from the core dataset. Finally, 59 confirmed genes related to eating disorder were stored in this core dataset, including three overlapping subsets: 52 genes related to anorexia nervosa, 19 genes related to bulimia nervosa, and 25 genes related to eating disorder. Among these 59 genes, 33, 31 and 20 were related to obesity, schizophrenia and bipolar disorder, respectively. Further empirical re-sampling demonstrated that eating disorder was closely related to obesity, schizophrenia and bipolar disorder in genetics, which were all significantly related to the 59 genes related to eating disorder (see section 4.5).
So far gene-set enrichment analysis is probably the most practical and successful data mining approach for addressing the challenge of analyzing complex gene lists [35] . Here, we employed KEGG and BioCarta pathway enrichment analysis to summarize the possible signaling mechanisms of eating disorder. As listed in Table 1 , the top 10 enriched pathways were mostly related to endocrine and nervous system signaling pathways, amino acid metabolism as well as fat deposit and metabolism. The statistical enrichments of amino acid metabolism could be explained by the MAOA (monoamine oxidase A) and MAOB (monoamine oxidase B) genes, which are involved in the metabolism of several amino acids tyrosine, tryptophan, phenylalanine and histidine. Because of their vital roles in the inactivation of neurotransmitters, both genes were thought to be related to neural disorders such as Parkinson's disease [36, 37] .
Expanding candidate genes by protein-protein interactions and related diseases
The above mentioned systematic collection had limited success in discovering confirmed causal genes of eating disorder. Earlier studies showed that protein-protein interaction network, gene co-expression network and pathway enrichment analysis may provide a practical approach to expand the gene list and unveil the underlying molecular mechanisms [38] . We therefore set up a pathway discovery strategy to expand signaling mechanisms behind eating disorder combining protein-protein interactions, gene cytobands and related diseases. Seven raw datasets were prepared for the gene list expansion, including two datasets from the literature (see Materials and methods), three related disease (obesity, bipolar disorder and schizophrenia) datasets from Gene Association Database [5] , one interaction dataset (genes interacting with genes from the core dataset) and one cytoband dataset (genes sharing cytobands with genes from the core dataset). First, we added 107 genes (hereafter referred to as EXP1 dataset) from the two literature datasets as they were also present in the other five related raw datasets. Next, for the second expansion (hereafter referred to as EXP2 dataset) 148 genes were added from the three disease datasets, as they also had support from the interaction and cytoband datasets. With more than two direct functional confirmations, the 255 genes from the EXP1 and EXP2 datasets were convincingly important in the pathogenesis of eating disorder, making them very good candidates for further functional investigations. The third expansion was 793 genes (hereafter referred to as EXP3 dataset) with evidence from only three disease datasets. The last one was 1775 genes (hereafter referred to as EXP4 dataset) with support only from the protein interaction dataset.
Once the extension of candidate genes was achieved, a subsequent interpretation task was required to evaluate the biological roles of the expanded genes. Because most of the genes play a wide variety of roles in different cellular functions, great caution was taken to avoid introducing nonspecific pathways to data interpretation. Our pathway context analysis was conducted using a hypergeometric statistical comparison. Each expansion was involved in several signaling pathways, including the calcium signaling pathway, long-term depression, Gap Junction and PPAR (peroxisome proliferator-activated receptor) signaling pathway (Table S1 in Supporting Information). Some of these pathways, e.g., Gap Junction and long-term depression, should perhaps be considered as generic rather than specific pathway, indicating the presence of general processes in neural disorders. Interestingly, only neuroactive ligand-receptor interaction and the adipocytokine signaling pathway were always present in the top 10 pathways in the different datasets. They are intuitively linked with eating disorder, because of their close relationships with neural activity. However, in the KEGG pathway, the neuroactive ligand-receptor interaction was only a list of interaction pairs between neuroactive signaling molecules and their receptors instead of a fully connected map. Thus, it was very difficult to achieve a connected molecular network. On the contrary, the adipocytokine signaling pathway is a fully connected graph. More interestingly, adipocytokines such as leptin and adiponectin are important signaling molecules involved in neuronal circuits for food intake and are related to obesity, insulin resistance and cancer [39] [40] [41] [42] [43] [44] .
Identifying representative genes in the adipocytokine signaling pathway related to eating disorder
Although leptin and adiponectin in the adipocytokine signaling pathway are related to anorexia nervosa and bulimia nervosa [45, 46] , other downstream signaling circuits have not been reported to be related to eating disorder. Based on our gene collection, most of the genes in the adipocytokine signaling pathway are related to eating disorder ( Figure 3 ). Six genes in the core dataset, including LEP (leptin), LEPR (leptin receptor), ADIPO (adiponectin), POMC (proopio-melanocortin), AGRP (agouti related protein homolog) and NPY (neuropeptide Y), were annotated to the adipocytokine signaling pathway. LEP, LEPR and ADIPO are the most important upstream signals for food intake [42, 47] . The remaining three genes, POMC, AGRP and NPY, also play important roles in downstream signals in weight regulation or food intake [48] [49] [50] [51] . Because of equally negative and positive reports, TNF (tumor necrosis factor) was not included in the core dataset, but only in the EXP1 dataset. TNF interferes with the early steps of insulin signaling [52, 53] . Moreover, three genes including SOCS3 (suppressor of cytokine signaling 3), PPARGC1A (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) and ACC2 (acetyl-CoA carboxylase beta) were included in the EXP1 dataset. Both PPARGC1A and ACC2 are involved in the regulation of fatty acid oxidation [54, 55] . Though SOCS3 cannot directly influence fatty acid oxidation, it inhibits leptin activation of AMPK (5′ AMP-activated protein kinase) [56] . In summary, 10 genes from the core dataset and the EXP1 dataset can be clustered into two categories: (i) four upstream signals including TNF, LEP, LEPR and ADIPO, which are related to obesity; (ii) six downstream effector molecules of metabolic regulation, among which five were also related to obesity. As genes from both the core dataset and the EXP1 dataset are shown to be involved in eating disorder, our next task was to fill in the gap between highly convincing upstream signals and downstream effector genes with data from protein-protein interactions and related disease studies.
As shown in Figure 3 , five genes from EXP2 are colored in the map. Three of them are receptors for ADIPO and TNF. The remaining two genes, STAT3 (signal transducer and activator of transcription 3) and RXR (retinoid X receptor, alpha), are intermediate regulators in the adipocytokine signaling pathway. Furthermore, 10 genes from EXP3 and eight genes from EXP4 were introduced into the adipocytokine signaling pathway. Finally, all the gaps between upstream signals and downstream molecules were filled in the map with only four genes (MTOR (mechanistic target of rapamycin), JNK (c-Jun N-terminal kinase), IKK (IB kinase) and PRKCQ (Protein Kinase C, Theta)), which were not included in EDdb. Combining the four expansion datasets, we identified 33 genes in the adipocytokine signaling pathway, among which 20, 13 and 4 were associated with obesity, schizophrenia and bipolar disorder, respectively. In particular, the high proportion of obesity related genes in the adipocytokine signaling pathway may provide clues for explaining weight regulation in both diseases.
Key joint signaling map for eating disorder combined from the "adipocytokine signaling pathway" and "visceral fat deposits and the metabolic syndrome"
Different pathway databases have various pathway concepts [31, 57] . The real cellular communications are dynamic and have no artificial boundaries. Connecting and combining common pathways from different databases through their cross-talking molecules is a direct approach to extend pathway paradigms. Our in-depth analysis of the top 10 statistically representative pathways in Table 1 revealed that the "reversal of insulin resistance by leptin" pathway from BioCarta is a complete subset of the "adipocytokine signaling pathway" from KEGG. Meanwhile, the "visceral fat deposits and the metabolic syndrome" pathway from BioCarta and the "adipocytokine signaling pathway" from KEGG can be combined together to form a fully connected map. "Visceral fat deposits and the metabolic syndrome" pathway contains eight molecules, among which three downstream or mid-stream genes (ADIPO, TNF and RXR) are the same upstream or mid-stream molecules found in the "adipocytokine signaling pathway". The remaining five Upstream molecules include PPARG (peroxisome proliferatoractivated receptor gamma), HSD11B2 (hydroxysteroid 11-beta dehydrogenase 1), NR3C1 (nuclear receptor subfamily 3, group C, member 1), LPL (lipoprotein lipase) and REST (resistin), among which REST and NR3C1 have been confirmed to be related to eating disorder [5860]. In addition, PPARG and LPL are both from the KEGG "PPAR signaling pathway". Furthermore, at least five genes in Figure 3 , including LPL, PEPCK (phosphoenolpyruvate carboxykinase), CPT1A (carnitine palmitoyltransferase 1A), FACS (acsl1 acyl-CoA synthetase long-chain family member 1) and FAT/CD36 (fatty acid translocase/cluster of differentiation 36), are regulatory targets of PPARG/RXR, PPARD/RXR and PPARA/RXR. Thus, these genes form a highly linked regulatory module, bridging the "PPAR signaling pathway" and the "adipocytokine signaling pathway", hence highlighting the potential roles of these genes in the pathogenesis of eating disorder. In summary, 43 genes, mainly from the "visceral fat deposits and the metabolic syndrome" pathway and the "adipocytokine signaling pathway" are interlinked through regulatory relationships between ADIPO, TNF and NR3C1. Other genes in our database, such as GSK3B (glycogen synthase kinase 3 beta), from other relevant signaling pathways could also be connected to our summarized key joint signaling map ( Figure  3 ). More importantly, 39 among the 43 genes are stored in our EDdb, and 25 of them are associated with obesity.
We observed a few more regulatory modules in the summarized key signaling map (Figure 3 ), for instance, the upstream regulatory module consisting of ADIPO, PPARG/ RXR, HSD11B2 and NR3C1, and another regulatory module, which is centered around LEPR, SOCS3 and JAK (Janus kinase). Cooperation of these coupled loops may transmit upstream signals to downstream cellular systems in fast or slow manners. Overall, our integration of several pathways from the BioCarta and KEGG databases revealed that eating disorder is a complex process caused by dysregulation of multiple highly interconnected pathways.
Reconstruction of a core pathway for eating disorder genes using sub-network extraction from protein-protein interaction data
The integrative pathway analysis above gave us a clue on how to reconstruct a core pathway for eating disorder. Here to reconstruct a potential biological process based on known protein-protein interactions in our EDdb, we firstly adopted a sub-network extraction approach. To get a comprehensive picture of eating disorder, we pieced together the protein-protein interaction data from the HPRD (Human Protein Reference Database), IntAct, BioGRID (Biological General Repository for Interaction Datasets) and MINT (Molecular INTeraction) databases. Based on 59 genes in our core dataset as seed, we used the Klein-Ravi algorithm to extract a sub-network from the integrated human protein-protein interaction (PPI) network (see Materials and methods). The final sub-network contains 78 genes in total (Figure 4) . Fifty-three genes were in our eating disorder core dataset and the remaining 25 genes were linked to the 53 genes, forming a fully connected network. Functional enrichment analysis showed that the 78 genes in our reconstructed sub-network were enriched in six pathways ( Table  2 ). The pathways "neuroactive ligand-receptor interaction", "adipocytokine signaling pathway" and "visceral fat deposits and the metabolic syndrome" were the same as the enriched pathways in Table 1 . The related pathways of three neurotransmitters including "serotonergic synapse", "cocaine addiction", and "dopaminergic synapse" were also detected. These results not only confirm the potential cen- tral role of adipocytokine signaling in eating disorder, but also provide more clues on signaling pathways related to other neurotransmitters.
Discussion
The high genetic heterogeneity of eating disorder poses an enormous challenge in understanding the disease etiology. Classical identification of candidate genes for complex disorders has been conducted experimentally. However, these individual studies for identifying specific genes/variants predisposed to eating disorder from different technology platforms are seldom incorporated with known biological information such as common pathways between eating disorder and other metabolic and psychiatric disorders. Heterogeneous data source integration might remove bias resulting from any single technology platform, and systems biology approach could provide additional insight into the genetic etiology not observed by any individual study [6164] . Our EDdb is a high-quality resource containing genetic data from association studies, linkage scans, gene expression, literature, Gene Ontology (GO) annotations, and metabolic and signaling pathways. Each confirmed gene in our core dataset is linked with highly referred citations. By integrating protein-protein interactions and related disease data, we expanded the candidate genes for eating disorder to broader molecular networks. Our collection shows that 59 genes have been confirmed to be linked to eating disorder. Moreover, our systematic pathway and sub-network reconstruction revealed that the adipocytokine signaling pathway may be the central signaling pathway in eating disorder. Combining the upstream signaling events in the BioCarta pathway of "visceral fat deposits and the metabolic syndrome" with the KEGG "adipocytokine signaling pathway", we propose a key joint signaling map for weight regulation in eating disorder, which may serve as an interesting hypothesis for further experimental testing. For instance, from the upstream signaling molecules of the "visceral fat deposits and the metabolic syndrome" pathway, only HSD11B2 is in EXP3 with indirect evidence, while all the remaining seven genes have literature support. HSD11B2 is the enzyme that regulates the glucocorticoid metabolism. The interaction between glucocorticoid and insulin is a very important signal for regulating long-term energy metabolism [64] . In particular, NR3C1, the downstream gene of HSD11B2, has been reported to be associated with glucocorticoid resistance, eating disorder and obesity [58, 66] . Therefore, it is highly possible that HSD11B2 is related to eating disorder. Other highly potential genes include four genes (MTOR, JNK, IKK and PRKCQ), which are absent from EDdb. These genes form a connected module centered around PRKCQ in response to the diacylglycerol signal and ensure cell survival and proliferation [67] . It has been reported that mouse Prkcq affects fat-induced insulin resistance and glucose transport [68] , thus it is possible that the human PRKCQ is involved in insulin resistance and may also be involved in eating disorder.
Comparison of pathway contents demonstrated that eating disorder is strongly associated with obesity, schizophrenia and bipolar disorder. All four upstream signals (TNF, LEP, LEPR and ADIPO) from our core dataset and EXP1 dataset are shared with obesity, and five of the six downstream effector molecules are also shared with obesity. In our key signaling map, 25 of the 43 genes are associated with obesity. Such a high proportion of obesity-related genes in the map may provide clues for explaining some features of weight regulation in both diseases related to unhealthy lifestyle.
An interesting point to be emphasized is that the majority of the molecules in our proposed key signaling pathway are functional elements such as transcriptional regulators related to neuronal and synaptic function or key enzymes in metabolism. Therefore, the final pathway size underlying the etiology of eating disorder tends to be larger when more involved molecules are added. In summary, the level of complexity of the disorder stems from its functional components such as transcriptional regulators and key enzymes.
In conclusion, these analyses demonstrate that EDdb is a valuable tool for discovering potential candidate genes and pathways of eating disorder, as well as potential cross-talk between obesity and eating disorder. As a result of systematically collected and extended candidate genes, EDdb may also be helpful in explaining the underlying molecular mechanisms of eating disorder.
Conclusion
EDdb was constructed as a free database and analysis server to enable biochemists to quickly find summarized genes related to eating disorder. Our systematic pathway studies revealed that a key joint pathway combining the KEGG "adipocytokine signaling pathway" and the BioCarta pathway of "visceral fat deposits and the metabolic syndrome" may be the central signaling pathway of weight regulation, linking eating disorder with other relevant diseases such as obesity. The EDdb database can be accessed at http://eddb. cbi.pku.edu.cn. 
